• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
INCY

INCY

Incyte Corporation

NASDAQHealthcareBiotechnologyUS

USD97.98

+5.74 (+6.22%)

Rating:A

Company Profile

CEO

William J. Meury

IPO Date

1993-11-04

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$93.02

Prev. Close

$92.24

Day Low

$92.66

Day High

$98.42

52W Low

$66.30

52W High

$112.29

Market Cap

$19.57B

Volume

2.18M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.7%

Avg Negative

1.6%

Avg Neutral

68.8%

News Feed

Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report?

zacks.com·5/28/2026·↓ negative

Incyte to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

gurufocus.com·5/26/2026·↑ positive

Incyte Sets Mid-Year Phase 3 Trial for CALR Antibody 989 as Pipeline Updates Roll Out

marketbeat.com·5/25/2026·↑ positive

Why Incyte (INCY) is a Top Growth Stock for the Long-Term

zacks.com·5/21/2026·↑ positive

Inside Incyte's $120 Million AI For Drug Development Deal

forbes.com·5/20/2026·↑ positive

Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery

businesswire.com·5/20/2026·↑ positive

Incyte Corporation (INCY) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

seekingalpha.com·5/19/2026·↑ positive

Incyte and Edison Scientific Announce Strategic Collaboration to Employ the Kosmos AI Platform for Research and Development

businesswire.com·5/19/2026·↑ positive

Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build

marketbeat.com·5/18/2026·↑ positive

Incyte Corporation (INCY) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

seekingalpha.com·5/13/2026·↑ positive